POLIOMYELITIS: A REVIEW
Abstract
Poliomyelitis presents as acute febrile illness withsudden onset of weakness of extremities. It is causedby type 1,2, and 3 poliovirus and spreads mostcommonly by faecal-oral route, particularly in areaswith poor sanitation.1'2 It is primarily a disease ofchildren, 70-90% of the cases occur in those less than3 years of age. 3 The disease is preventable throughimproved sanitation, hygiene and immunization withpolio vaccines.In May 1988, World Health Assembly (WHA)declared that World Health Organization (WHO) wascommitted to the global eradication of poliomyelitisby the year 2000.4 Substantial progress towards theglobal eradication of poliomyelitis by the year 2000has been achieved since May 1988. Today the worldstands on the brink of achievement of goal of globalpoliomyelitis eradication, under the leadership ofWHOReferences
Bodian D, Horstmann DM. Poliovirus. In: Horsfall FL
Jr, Tamm I. Eds. Viral and Reckettsial Infection of
Man. 4th Ed. Philadelphia: JB Lippincott Company,
; 430-73.
Shandera S, Gill F.P, Infectious diseases: Viral and
Reckettsial. In: Lawemce M, Tierney JR, Stephen J,
McPhee Maxine. VP, eds. Current Medical Diagnosis
and 'treatment. 33rd Ed. Norwalk: Appleton and Lange,
: 1096-1128.
Hull HF, Ward NA, Hull BP, Milstein JB, deQuadros
C, Paralytic poliomyelitis: Seasoned strategies,
disappearing disease. Lancet 1994; 343: 1331-37.
WHO. Expanded programme on immunization (EPI):
Reported trends of EPI disease in Europe. Weekly
Epidemiol Rec 1988; 63:81-84.
Tangermann RH, Aylward P, Birmingham M, et al.
Current status of the global eradication of
poliomyelitis. World Health Statis Quart 1997; 50: 188-
Nakajima II. World Health Day 1995. Target 200-A
world without polio. World Health 1995; 1:3.
CDC. Progress towards global eradication of
poliomyelitis, 1988-1993. MMWR 1994; 43(27): 499-
Lodhi ZH. National polio immunization day 1994
Pakistan report. Fed EPl Cell NH 1994:1.
Could T. But the malady lingers on - Summer plague.
Reviews Angier Carol J Spectator 1995; 274: 39.
Garrison FH, ed. History of Medicine. 4Ul Ed. London:
WB Saunders Company, 1960: 638.
Melnick JL. Enteroviruses. In: Evans AS, ed Viral
Infections of Humans, Epidemiology and Control. New
York: Plenum Medical Book Company, 1976; 163-207.
WH O Tech Report Series. Expert Committee on
Poliomyelitis. First Report.
Gamble DR. Enteroviruses; polio, echo, and coxsackie
virus. In: Wilson G, Miles A, Parker MT, eds. Topley
and Wilson’s Principles of Bacteriology, Virology and
Immunity. 7dl Ed. 19X4: 4:1342.
Anonymous. Epidemic on otterereck. 1994; 58(7): 122.
Anonymous. End of the road for poliomyelitis? Nature
; 374: 663. Anonymous. Destruction of small pox
virus by 1999. UN Chronicle 1996; 33(2):79.
Silverstein AM, ed. A History of Immunology. New
York Academic Press. Inc. 1989; 107.
Minor PD, Bell EJ. Pieomaviridae (excluding
rhinovirus). In: Collier LH, Tibmury MC. eds. Topley
and Wilson’s Principles of Bacteriology, Virology and
Imminity. 7'1' Ed. London: Edward Arnold 1990: 324-
White DO. Fenner F. eds. Medical Virology. 3ld Ed.
New York Academic Press, 1986: 451-78.
Henderson RH. The WHO plan of action for global
eradication of poliomyelitis by the year 2000. Ann NY
acad Sci 1989; 509: 69-85.
Hull FH, Aylward RB. Ending polio immunization.
Science 1997; 277: 780.
Horstman DM. Control of poliomyelitis. A continuing
paradox. J Infect Dis 1982: 146:504-51.
WHO. Poliomyelitis in 1985. Part I and 2. Weekly
Epidemiol Rec 1987: 62:273-82.
WHO Geographical distribution of poliomyelitis cases.
Week Epid Record 1995; 70(14): 100-101.
WHO. Expanded programme on immunization (EPI).
Progress towards poliomyelitis eradication, 1995.
Week Epidemiol Recc 1996; 71:189-96,253-260.
Stanway G, Cann AJ, Hauptmann R, et al. The
nucleotide sequence of poliovirus type 31eon 12 AB:
Comparison with poliovirus type 1. Nucleic Acids Res
; 11(16):5629-43.
Bums SM, Ignlis JM. Picornaviruses. In: Greenwood
D, Slack
RCB. Peutherer .IE, eds. Medical Microbiology; A
guide to Microbial Infections: Pathogenesis Immunity,
Laboratory
JAMC, Vol. 12, 2, 2000
Diagnosis and Control. 14th Ed. London: Churchill
Livingstone. 1992; 549-54.
Minor PD, Ferguson M, Evans DMA, Almond JW,
Icenogle JP. Antigenic structure of polioviruses of
serotypes 1,2 and 3. J Gen Virol 1986; 67:12X3-91.
Rueckert RR. Picornaviridae and their replication. In:
Fields BN, Knipe DM. Virology. 2"d Ed. New York:
Raven Press Ltd., 1990: 507-48.
Melnick JL. Enteroviruses: Polioviruses,
coxsackieviruses, echoviruses and new enteroviruses.
In: Field BN, Knipe DM. et al. Virology. 2nd Ed. New
York: Raven Press, 1990: 549-605.
Putnak JR, Phillips BA. Picornaviral structure and
assembly. Microbiol Rev 1981; 45:287-315.
Yogo Y, Wimmer FI Polyadenylic acid at the 3’
terminus of poliovirus RNA. Proc Nat Acad Sci (USA)
; 69: 1877-82.
Meissner C. Polio and other enteroviruses. In:
Schachter M, Med off G, Schlesinger D, eds.
Mechanism of Microbial Disease. London: Williams
and Wilkins 1989: 462-70.
Pelletier J, Sonenberg N. Nature 1988: 334-320.
WHO. Manual for the virological investigation of
poliomyelitis. “Poliomyelitis eradication by the year
” EPI/Polio 1990: 32-80.
Sabin AB. Pathogenesis of poliomyelitis: Reappraisal
in the light of new data. Science 1956; 123:1151-57.
Howe HA, Wilson JL. Poliomyelitis. In: River TM,
Horsfall FL Jr, eds. Viral and Rickettsial Infection of
Man. 3rd Fid. Philadelphia: JB Lippincott Company,
; 432-79.
Eichner M, Dietz K. Eradication of poliomyelitis:
When can one be sure that poliovirus transmission has
been terminated. AmJ Epidemiol 1996; 143(8):816-22.
Ogra PL. Mucosal immune response to poliovirus
vaccines in childhood. Rev Infect Dis 1984; 6(Suppl 2):
S361-S68.
Paul JR, Riordan JT, Melnick JL. Antibodies to three
different antigenic types of poliomyelitis virus in sea
from North Al- Askan Eskimos. Am J Hyg
:54:275-85.
Hull HE. Lee JW. Sabin, Salk or sequential? Lancet
; 347:630.
Schouh BD, Johnson S, Mcannervey JM, Kustner
PIGV, Merwe CAVD. A comprehensive investigation
of immunity to poliomyelitis in a developing country.
Am J Epidemiol 1986; 123:316-24.
Simmons A. Marmion BP. Laboratory diagnosis of
virus injections. In: Collee JG, Marmion BP. Fraser
AG, Simmons. A eds. Practical Medical Microbiology.
th Ed. New York: Churchill Livingstone, 1996; 637-
Melnick JL, Wenner HA, Philips CA. Enteroviruses.
In: Lennette EH, Schmidt NJ, eds. Diagnostic
Procedures for Viral, Reckettsial and Chlamydial
Injections. 51*1 Ed. Washington DC: American Public
Health Association, 1979; 471-534.
Lamb G.A Plexico K. Glezen WP, Chin TDY. Use of
microtechnique for serum neutralization and vims
identification. Public Health Rep 1965: 80(5):463-66.
Melnick JL. Enterovirus type 71 infections: A varied
clinical pattern sometimes mimicking paralytic
poliomyelitis. Review Infect Dis 1984; 6:387-90.
Jawetz E, Melnick JL., Adelberg EA (eds). Review of
Medical Microbiology. California: Appleton and Lange
: 432-6.
Ghendon Y, Robertson SE. Interrupting the
transmission of wild polioviruses with vaccines
immunological consideration. Bull WHO 1994;
:973-83.
Msambichaka KA. The role of women. World Health
; 1:28.
Wright PF, Kim-Farley RJ, deQuadros CA et al.
Strategies for the global eradication of poliomyelitis by
the year 2000. N Engl J Mel 1991; 325: 1994-79.
Banerjee C, Horstmann DM. Poliovirus. In: Horsfall
FL Jr, Tamm I, eds. Viral and Rickettsial Infection of
Man. 4* Ed, Philadelphia: JB Lippincott Company,
; 430-73.
Melnick JL. Advantages and disadvantages of killed
and live poliomyelitis vaccines. Bull WIIO 1978;
:21-38.
Salk J, Salk D. Control of influenza and poliomyelitis
with killed vims vaccines. Science 1977; 195:834-46.
McBean Am, Thomas ML, Johnson RH. et al. A
comparison of the serologic responses to oral and
injectable trivalent poliovirus vaccines. Rev Infect Dis
; 6(Suppl 2): S552- S55.
Onorato IM, Modlin JF. McBean AM, Thomas ML,
Losonsky GA Bernier RFI. Mucsoal immunity induced
by enhanced- potency inactivated andoral polio
vaccines. J Infect Dis 1991; 163:1-6.
Sutter RW, Patriarca PA Brogan S, et al. Outbreak of
paralytic poliomyelitis in Oman: Evidence for
widespread transmission among fully vaccinated
children. Lancet 1991; 338:715-20.
Andrus JK, Strebel PM, deQuadros C, Olive JM. Risk
of vaccine-associated paralytic poliomyelitis in Latin
America 1989-91. Bull WHO 1995; 73(l):33-40.
Almond JW, Stanway G, Cann AJ, et al. New
poliovirus vaccines a molecular approach vaccine
; 2:177-84.
Svitkin YV, Maslova Sv, Agol VI. The genomes of
attenuated and virulent poliovirus strains differ in them
in vitro translation efficiencies. Virology 1985;
:243-52.
Hashmi IQJ, Tayyab M, Ditta A Asghar H. A
virological study of suspected cases of poliomyelitis
(Under publication). Pak Postgraduate Med J, 1998
Issue
Section
License
Journal of Ayub Medical College, Abbottabad is an OPEN ACCESS JOURNAL which means that all content is FREELY available without charge to all users whether registered with the journal or not. The work published by J Ayub Med Coll Abbottabad is licensed and distributed under the creative commons License CC BY ND Attribution-NoDerivs. Material printed in this journal is OPEN to access, and are FREE for use in academic and research work with proper citation. J Ayub Med Coll Abbottabad accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing in J Ayub Med Coll Abbottabad. The Editorial Board of J Ayub Med Coll Abbottabad makes every effort to ensure the accuracy and authenticity of material printed in J Ayub Med Coll Abbottabad. However, conclusions and statements expressed are views of the authors and do not reflect the opinion/policy of J Ayub Med Coll Abbottabad or the Editorial Board.
USERS are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.
AUTHORS retain the rights of free downloading/unlimited e-print of full text and sharing/disseminating the article without any restriction, by any means including twitter, scholarly collaboration networks such as ResearchGate, Academia.eu, and social media sites such as Twitter, LinkedIn, Google Scholar and any other professional or academic networking site.
